Chad Tang

16PUBLICATIONS

163CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyCartography and digital mappingMolecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|May 16, 2026

Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial.

|Dec 13, 2025

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Oct 03, 2025

Reply to: Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial Insights.

Phuoc T Tran, Jarey H Wang, Chad Tang

|Aug 06, 2025

Feasibility of Longitudinal Relaxation Rate Mapping with Non-Cartesian Sampling and Compressed Sensing on a 1.5T MR-Linac.

Lucas McCullum, Michael J van Rijssel, Ken-Pin Hwang

|May 14, 2025

Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled Trial.

Comron Hassanzadeh, Deborah Kuban, Sarah Pasyar

|May 07, 2025

Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Jarey H Wang, Alexander D Sherry, Soha Bazyar

Pageof 3

Frequent Collaborators

Alexander D Sherry

Pavlos Msaouel

Ethan B Ludmir

Phuoc T Tran

Avital M Miller

Surena Matin

Tharakeswara K Bathala

2 joint publications

Timothy A Lin

2 joint publications

Joseph Abi Jaoude

2 joint publications

Ramez Kouzy

Frequent Collaborators

Alexander D Sherry

Pavlos Msaouel

Ethan B Ludmir

Phuoc T Tran